Skip to main content

$3.33 0.01 (0.30%)

High

$3.34

Low

$3.32

Trades

122

Turnover

$518,004

Volume

155,585
30 June 2023 at 4:10pm
Register to track SLA and receive email alerts.
Subject
SLA Ann: Becoming a substantial holder

SLA Ann: Wesfarmers Health and SILK enter Scheme Implementation Deed

SLA Ann: SILK Enters into Binding Implementation Deed with API

SLA Ann: Ceasing to be a substantial holder from WAM, WMI, WAX

SLA Ann: Change in substantial holding

SLA Ann: Change in substantial holding from WAM, WMI, WAX

SLA Ann: Expiry of Process Deed and Intention to Recommend Proposal

SLA Ann: Notice of ceasing to be a substantial holder from WES

SLA Ann: API Does Not Exercise Matching Rights Under Process Deed

SLA Ann: Superior Proposal from EC Healthcare

SLA Ann: Notice of initial substantial holder from WES

SLA Ann: WES: Wesfarmers Health proposal to acquire SILK Laser Aust

SLA Ann: Non-Binding Indicative Acquisition Proposal From API

SLA Ann: Change of Director's Interest Notice - Martin Perelman

SLA Ann: Notification regarding unquoted securities - SLA

SLA Ann: Change in substantial holding

SLA Ann: SILK completes acquisition of Eden Laser Clinics

SLA Ann: SILK delivers another half of revenue and earnings growth

SLA Ann: SILK H1 FY23 Results Presentation

SLA Ann: Appendix 4D & FY23 Half-Year Financial Statements

SLA Ann: H1 FY23 Results and Investor Briefing Details

SLA Ann: SILK to expand NSW footprint with acquisition of Eden Laser

SLA Ann: New Constitution

SLA Ann: 2022 AGM - Results of Meeting

SLA Ann: 2022 AGM Presentation

SLA Ann: Notice of 2022 Annual General Meeting and Proxy Form

SLA Ann: Corporate Governance Statement & Appendix 4G

SLA Ann: 2022 Corporate Governance Statement & Appendix 4G

SLA Ann: 2022 Annual Report

SLA Ann: Date of AGM and Closing Date For Director Nominations

SLA Ann: Change of Director's Interest Notice - Sinead Ryan

SLA Ann: Change of Director's Interest Notice - Jacinta Caithness

SLA Ann: Change of Director's Interest Notice - Boris Bosnich

SLA Ann: Notice under Section 708A(5) of the Corporations Act

SLA Ann: Application for quotation of securities - SLA

SLA Ann: Notification of cessation of securities - SLA

SLA Ann: Application for quotation of securities - SLA

SLA Ann: FY22 Results Investor Presentation

SLA Ann: SILK Beats FY22 Guidance, Continues Growth Trajectory

SLA Ann: Appendix 4E & Preliminary Financial Report - 30 June 2022

SLA Ann: Change of Director's Interest Notice - Martin Perelman

SLA Ann: Notification regarding unquoted securities - SLA

SLA Ann: Release from Voluntary Escrow

SLA Ann: FY22 Results and Investor Briefing Details

SLA Ann: SILK launches Australian-first day procedure centres in Tas

SLA Ann: SILK acquires Unique Laser - additional information

SLA Ann: SILK acquires Unique Laser, expands network to 128 clinics

SLA Ann: SILK on track for $20M EBITDA, ahead of analyst consensus

SLA Ann: Initial Director's Interest Notice - Jacinta Caithness

SLA Ann: Final Director's Interest Notice - Bradley Lynch

Register to track SLA and receive email alerts.

Similar Companies

AHX
BD1
CAJ
HLA
HLS
IDX
RHY
SHL
TTB